APA (7th ed.) Citation

GD, H., Y, S., HX, H., MY, T., YQ, L., & J, Z. (2021). MiR-1224 Acts as a Prognostic Biomarker and Inhibits the Progression of Gastric Cancer by Targeting SATB1. Frontiers in oncology, 11, 748896. https://doi.org/10.3389/fonc.2021.748896

Chicago Style (17th ed.) Citation

GD, Han, Sun Y, Hui HX, Tao MY, Liu YQ, and Zhu J. "MiR-1224 Acts as a Prognostic Biomarker and Inhibits the Progression of Gastric Cancer by Targeting SATB1." Frontiers in Oncology 11 (2021): 748896. https://doi.org/10.3389/fonc.2021.748896.

MLA (9th ed.) Citation

GD, Han, et al. "MiR-1224 Acts as a Prognostic Biomarker and Inhibits the Progression of Gastric Cancer by Targeting SATB1." Frontiers in Oncology, vol. 11, 2021, p. 748896, https://doi.org/10.3389/fonc.2021.748896.